abhadya chura and mukta bhasma in the management of Ashthi Kshaya.
Phase 3
Completed
- Conditions
- Health Condition 1: M199- Osteoarthritis, unspecified siteHealth Condition 2: null- patients of either sex inbetween 45 to 65 years. BMDT score -1
- Registration Number
- CTRI/2017/05/008614
- Lead Sponsor
- CCRAS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 65
Inclusion Criteria
BMD T score less than -1
Exclusion Criteria
fragidity of bone, endocrine dis0rders,patients having poorly controlled hypertension, serum calcium less than 2.6 and more than 10.5 mg/dl
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change in quality of life index,Timepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method change BMD Tscore, Bone specific alkaline phospatase changeTimepoint: 12 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of abhadya chura and mukta bhasma in osteopenia/osteoporosis management?
How does the combination of abhadya chura and mukta bhasma compare to bisphosphonates in improving BMDT scores in postmenopausal women with osteoporosis?
Are there specific biomarkers that correlate with response to abhadya chura and mukta bhasma in Ashthi Kshaya patients aged 45-65 years?
What adverse events are associated with abhadya chura and mukta bhasma treatment in phase III clinical trials for osteopenia/osteoporosis?
What are the potential synergistic effects of combining abhadya chura and mukta bhasma with calcium or vitamin D supplements in managing osteopenia?